Introduction {#s1}
============

Periodontitis is an inflammatory oral disease that affects nearly half of the population in the United States ([@B1]). It is characterized by dysbiosis within the oral microbiota ([@B2], [@B3]), which is associated with deregulation of the host immune response. Dysbiotic microbiota prolong the host response, leading to destruction of soft and hard tissues supporting the tooth ([@B4], [@B5]). Dendritic cells (DCs) are antigen-presenting cells (APCs) that circulate throughout the blood and enter peripheral tissues, where they capture microbes via pattern recognition receptors (PRRs) ([@B6], [@B7]). *Porphyromonas gingivalis* (*P. gingivalis*) is recognized as a keystone pathogen through its ability to manipulate the oral microbiome ([@B8]). DCs respond locally to *P. gingivalis-*induced dysbiosis ([@B6], [@B9]--[@B11]) and carry *P. gingivalis* in the bloodstream to distant sites ([@B12]). Several studies have reported the relationship between *P. gingivalis* and systemic diseases, including cardiovascular disease, respiratory tract infections, Alzheimer\'s disease, diabetes mellitus, and preterm low birth weight babies ([@B13]--[@B18]). *P. gingivalis* expresses many virulence factors, contributing to its defense and destruction against host tissues and cells, that are sensed by DCs via specific PRRs. Most notable are the adhesion proteins, known as fimbriae. Generally, two types of fimbriae are recognized on the surface of *P. gingivalis*, the major (FimA) fimbria, encoded by *fimA* gene, and minor (Mfa1) fimbria, encoded by *mfa1* gene ([@B19]). It has been reported that the *P. gingivalis* minor fimbria target the C-type lectin receptor DC-SIGN ([@B20], [@B21]), while the major fimbria target the Toll-like receptor 2 (TLR2) ([@B22], [@B23]).

Autophagy is central to the development of an efficient balanced immune response. The cellular autophagic machinery breaks down damaged proteins and organelles by sequestering and directing cargo to the lysosome. This same machinery is required for APCs to fight invading pathogens and shape cellular immunity ([@B24]) through antigen processing, upregulation of costimulatory molecules and cytokines ([@B25]--[@B27]). Apoptosis is another essential component of immune homeostasis. Inappropriate execution of apoptosis in immune cells can lead to dire consequences such as development of autoimmune diseases ([@B28]). We have recently shown that *P. gingivalis* subverts autophagy to survive in DCs through a mechanism involving the targeting of DC-SIGN by Mfa1 fimbria ([@B29]). This is involved in inhibition of apoptosis in host DCs ([@B30]) through a mechanism that is not clear.

High throughput RNA sequencing of MoDCs infected with *P. gingivalis* and its isogenic fimbriae deficient mutants, have identified a particular set of genes involved in the regulation of autophagy and apoptosis that are dependent on fimbriae-expression pattern ([@B31]). The present work has identified at the protein and functional level, the signaling pathway activated by *P. gingivalis* via its Mfa1 fimbriae, involved in both survival and disruption of immune homeostasis through regulation of both apoptosis and/or autophagy in DCs. We now show a pivotal role for nuclear/cytoplasmic shuttling of Akt/FOXO1 in autophagy downregulation by Mfa1 expressing *P. gingivalis*. Autophagy downregulation occurs concomitantly with an upregulation of Bcl2, decreased caspase-3 activation, and the downregulation of the pro-apoptotic proteins Bax and Bim.

Materials and Methods {#s2}
=====================

Ethical Aspects
---------------

*In vitro* monocyte-derived DCs (MoDCs) studies were determined by the Human Assurance Committee at Augusta University to be human subject exempt, due to the use of anonymized peripheral blood samples for monocytes.

Reagents
--------

Primary antibodies against Akt, Phosphorylated Akt (p-Akt) Ser473, FOXO1, p-FOXO1 Thr24, mTOR, p-mTOR Ser2448, Raptor, p-Raptor Ser792, ULK-1, p-ULK-1 Ser757, LC3B, Bax, Bim, Bcl2, Caspase 3, Cleaved caspase 3, Cleaved PARP, β-actin, GAPDH, horseradish peroxidase (HRP)-conjugated anti-mouse, and anti-rabbit secondary antibodies and protease/phosphatase inhibitor cocktail were purchased from (Cell Signaling Technology, Danvers, MA). MK2206 and ABT-199 were purchased from (Selleckchem, Houston, TX). HDAC1 antibody, chloroquine, rapamycin, Pam3csk, erythromycin, tetracycline, RIPA buffer and PVDF membranes were purchased from (Sigma-Aldrich, St. Louis, MO). 4--15% Mini-PROTEAN TGX Precast Protein Gel was from (Bio-Rad Laboratories, Inc., Hercules, CA). RPMI 1640 medium, ProLong™ Gold Antifade Mountant with DAPI, Annexin V FITC Apoptosis Detection Kit and NE-PER™ Nuclear and Cytoplasmic Extraction Reagents were purchased from (Thermo Fisher Scientific, Carlsbad, CA). EasySep™ Human Monocyte Enrichment Kit was from (STEMCELL Technologies Inc., Vancouver, Canada). GM-CSF, IL-4, FBS and antibiotic/antimycotic were from (Gemini Bio Products, West Sacramento, CA). Wilkins-Chalgren anaerobe broth from (Neogen Europe, Ltd., Scotland, UK). Western Lightning ECL Pro Chemiluminescent reagent (PerkinElmer Inc., Waltham, MA). RNeasy kit for RNA isolation was from (Qiagen, Germantown, MD). TaqMan® gene expression primers obtained from Thermo Fisher Scientific were used for Real-Time Quantitative Reverse Transcription PCR (qRT-PCR): *Bcl2* (Assay ID: HS00608023_m1), *Bax* (Assay ID: HS00180269_m1), *Bim* (Assay ID: HS00708019_s1) and *GAPDH* (Assay ID: Hs02758991_g1).

DCs Generation and Culture
--------------------------

Blood samples were obtained from healthy donors at Shepeard Community Blood Center (Augusta, GA). Monocyte-derived DCs were generated from monocytes isolated from fractions of peripheral blood by negative selection using EasySep™ Human Monocyte Enrichment Kit. After isolation, monocytes were seeded in the presence of GM-CSF (1,000 U/ml) and IL-4 (100 U/ml) at a concentration of 1--2 × 10^5^ cells/ml in RPMI 1640 containing 10% heat inactivated FBS and antibiotic/antimycotic for 5--7 days.

Culture of *P. gingivalis* Strains and DCs Infection
----------------------------------------------------

Three *P. gingivalis* strains were used in this study; Wild-type *P. gingivalis* (Pg381) which expresses both FimA and Mfa1 fimbriae, isogenic Mfa1 fimbria-deficient mutant (MFI) which expresses only FimA fimbriae, and isogenic FimA fimbria-deficient mutant (DPG3) which expresses only Mfa1 fimbriae. *P. gingivalis* strains were maintained anaerobically in (10% H~2~, 10% CO~2~, and 80% N~2~) in a Coy lab vinyl anaerobic chamber (Coy Laboratory Products, Inc., Grass Lake, MI) at 37°C in Wilkins-Chalgren anaerobe broth. Mutant strains were maintained using erythromycin (5 μg/ml) for mutant DPG3 and tetracycline (2 μg/ml) for mutant MFI ([@B32]). Bacteria suspension was washed five times and resuspended in PBS. CFUs were standardized at an OD of 0.11 at 660 nm (equivalent to 5 × 10^7^ CFU/ml) by spectrophotometry ([@B33]). DCs were pulsed with all *P. gingivalis* strains for either 6 or 12 h at a multiplicity of infection (MOI) = 1.

Total, Nuclear and Cytoplasmic Lysate Extraction
------------------------------------------------

Total cell lysates were extracted by addition of RIPA buffer supplemented by protease/phosphatase inhibitor cocktail and incubation for 20 min on ice. Samples were centrifuged and the supernatant was collected. The nuclear and cytoplasmic fractionation was done by using NE-PER™ Nuclear and Cytoplasmic Extraction Reagents following the manufacturer\'s protocol.

Western Blot
------------

Cellular protein was loaded into 4--15% Mini-PROTEAN TGX Precast Protein Gel and transferred to PVDF membranes. The membranes were blocked with 5% milk in TBST, followed by incubation overnight at 4°C with 1:1,000 dilution of primary antibodies. After membranes were washed three times in TBST, horseradish peroxidase-conjugated secondary antibodies were added at a 1:2,000 dilution and incubated for 1 h at room temperature. After three more washes with TBST, the immunoreactive peptide was detected by Western Lightning ECL Pro Chemiluminescent reagent and imaged using ChemiDoc™ MP Imaging System (Bio-Rad Laboratories, Inc., Hercules, CA).

Flow Cytometric Analysis
------------------------

Annexin V and propidium iodide (PI) detection was conducted by using eBioscience™ Annexin V FITC Apoptosis Detection Kit, according to the manufacturer\'s recommendation. Briefly, cells were harvested and washed once with PBS and once with 1X Annexin V binding buffer. Cells were resuspended with 1X binding buffer followed by incubation with Annexin V for 15 min at room temperature in the dark. After washes, samples were resuspended in 1X binding buffer and PI was added before running the samples by using MACSQuant® Analyzer 10 flow cytometer (Miltenyi Biotec Inc., Auburn, CA).

Immunofluorescence
------------------

Cell suspensions were deposited onto glass slides and centrifuged using Cytospin™ 4 Cytocentrifuge (Thermo Fisher Scientific, Carlsbad, CA). Cells were fixed with 4% paraformaldehyde for 10 min, washed with PBS, permeabilized with 0.1% Triton X-100 in PBS for 10 min and blocked for 30 min with 2% BSA in PBS. Primary antibody LC3 from was added to the cells and incubated overnight at 4°C. After washes, secondary antibody was added for 1 h, washed with PBS and slides were mounted with ProLong™ Gold Antifade Mountant with DAPI.

RNA Isolation and qRT-PCR
-------------------------

Total RNA was extracted from DCs using RNeasy kit following the manufacturer\'s protocol. Total RNA was reverse transcribed into cDNA. The cDNA was then amplified by PCR using the High-Capacity cDNA Reverse Transcription Kit® with random primers in total reaction of 20 μL.

Statistical Analysis
--------------------

Data analysis was conducted by one-way ANOVA followed by Tukey\'s multiple-comparisons test using GraphPad Prism 6 (GraphPad Software, Inc, La Jolla, CA). Values are expressed as mean ± standard deviation (SD). Experiments were carried out a minimum of three times.

Results {#s3}
=======

Differential Nuclear and Cytoplasmic Shuttling of Akt and FOXO1 and Attenuation of TLR1/2 Signal in *P. gingivalis*-Infected DCs
--------------------------------------------------------------------------------------------------------------------------------

Our previous study analyzed whole cell lysates of MoDCs, indicating that targeting of DC-SIGN receptor on DCs by *P. gingivalis* minor fimbriated strains induced phosphorylation of Akt and FOXO1 ([@B34]). To assess the function of these signaling/transcription factors, we analyzed nuclear/cytoplasmic shuttling of Akt and FOXO1 by Western blotting. We show that infection of MoDCs with Mfa1-positive Pg381 and DPG3, but not Mfa1-negative MFI, significantly increased induction of p-Akt and p-FOXO1 in the cytoplasm and nucleus ([Figure 1](#F1){ref-type="fig"}); however, the nuclear translocation of FOXO1 was significantly reduced in DCs infected with Pg381 and DPG3, in comparison to DCs infected with the Mfa1- negative MFI.

![*P. gingivalis* minor fimbria induces phosphorylation of Akt and FOXO1. DCs were infected with *P. gingivalis* strains, Pg381, DPG, and MFI for 6 h. Cytoplasmic and nuclear fractions were isolated from all groups. **(A)** Representative images of immunoblot analysis of Akt, p-Akt, FOXO1, and p-FOXO1 using cytoplasmic and nuclear extracts from uninfected DCs and DC infected with *P. gingivalis* strains. **(B)** Densitometric analysis of Akt, p-Akt, FOXO1, and p-FOXO1 in the cytoplasm and nucleus. After normalization of the phosphorylated protein with the corresponding total protein, the protein signal of control was set as 1, and the signals of other groups were normalized with control to calculate fold changes. GAPDH and HDAC1 were used as internal control for normalizing the data. Data are expressed as mean ± SD. \**P* \< 0.05, \*\**P* \< 0.01.](fimmu-10-02286-g0001){#F1}

Targeting of DC-SIGN by the minor fimbria protein is known to affect FimA-TLR2 activation ([@B22]). Here we used the agonist Pam3csk4 ([@B35]) to determine a possible counter-regulatory role for TLR2 in overriding Mfa-1-DC-SIGN signaling. DCs were treated with 1 μg/mL Pam3csk4 at the same time of *P. gingivalis* infection. Pam3csk4 treatment significantly attenuated Akt phosphorylation/activation caused by *P. gingivalis* infection, nearly equivalent to uninfected control DCs ([Figure 2](#F2){ref-type="fig"}).

![Selective activation of TLR1/2 attenuates the influence of DC-SIGN activation by *P. gingivalis* strains. Representative images of immunoblot and densitometric analysis of Akt and p-Akt. DCs were infected with *P. gingivalis* strains, Pg381, DPG, and MFI for 6 h. Some groups were treated with TLR1/2 ligand Pam3csk at the same time of infection. After normalization of the phosphorylated protein with total protein, the protein signal of control was set as 1, and the signals of other groups were normalized with control to calculate fold changes. GAPDH was used as internal control for normalizing the data. Data are expressed as mean ± SD. \*\*\**P* \< 0.001.](fimmu-10-02286-g0002){#F2}

*P. gingivalis* Inhibits Autophagy in DCs by Targeting DC-SIGN Via an Akt/mTOR-Dependent Mechanism
--------------------------------------------------------------------------------------------------

We next sought to determine how Akt activation by *P. gingivalis* affects autophagy through immunofluorescence staining of punctate LC3B-II. As expected, LC3B is diffuse in cytosol when autophagy is inhibited or absent, but when autophagy is activated, lipidated LC3B, referred to as LC3B-II, localizes to the autophagosome membrane resulting in punctate cytoplasmic staining ([@B36]). As shown ([Figures 3A,B](#F3){ref-type="fig"}), infection by Mfa1-positive Pg381 and DPG3 resulted in lower LC3 fluorescence (granular staining of LC3B) relative to uninfected DCs or DCs infected with Mfa1-negative strain MFI. A reduction in LC3B staining could indicate a reduction in autophagy or an enhancement of autophagic flux. We thus examined LC3B-II protein level after blocking autophagy flux using chloroquine (CQ) at a concentration of 5 uM. Blocking autolysosomal flux, allows steady state levels of LC3 to be compared between treatment groups. As shown in [Figures 3C,D](#F3){ref-type="fig"}, LC3B-II significantly accumulated in uninfected DCs and in DCs treated with rapamycin after treatment with chloroquine. In contrast, LC3B-II levels did not accumulate to higher levels in DCs infected with Pg381 or DPG3, supporting role in autophagy suppression in these cells. MFI-infected cells showed a small increase in LCBII in the CQ-treated cells, establishing that these cells expressed some level of functional autophagy, but the level is significantly less than that in DC control cells. These studies revealed that DCs infected with *P. gingivalis* strains induced autophagy defects, in particular, involving downregulation of LC3B-II.

![*P. gingivalis* minor fimbria decreases LC3B-II levels and autophagic flux. **(A)** Representative images of LC3 fluorescence staining. **(B)** Quantitative analysis of LC3 fluorescence intensity per unit area. **(C)** Representative images of immunoblot analysis of LC3B-II. **(D)** Densitometric analysis of LC3B-II. DCs were infected with *P. gingivalis* strains, Pg381, DPG, and MFI for 6 h. Some groups were treated with 1 μM rapamycin (Rapa). Each treatment was performed in duplicate to allow 5 μM chloroquine (CQ) to be added to each treatment group for the determination of LC3B-II steady state levels and autophagic flux. After normalization of LC3B-II to GAPDH, the protein signal of control was set as 1, and the signals of other groups were normalized and compared to control. Data are expressed as mean ± SD. \**P* \< 0.05, \*\*\**P* \< 0.001 (DC+CQ vs. Pg381 + CQ, DPG3 + CQ, MFI + CQ, and Rapa). ‡*P* \< 0.001 (Pg381 + CQ and DPG3 + CQ vs. MFI+CQ). †*P* \< 0.01 (Pg381 + CQ and DPG3 + CQ vs. MFI + CQ). §*P* \< 0.001 (Pg381 + CQ and DPG3 + CQ vs. Rapa + CQ).](fimmu-10-02286-g0003){#F3}

Akt/mTOR pathway, an important regulator of autophagy, was examined. Upon activation, Akt phosphorylates mTORC1, which in turn phosphorylates ULK1 at serine residue 757, which is known to inhibit autophagy ([@B37]). Infection with Mfa1-positive *P. gingivalis* strains induced expression of p-mTOR, p-ULK1 and Raptor ([Figure 4](#F4){ref-type="fig"}), consistent with the conclusion that p-Akt activation blocks autophagy induction. Rapamycin, a small molecule inhibitor of mTOR ([@B38]) was used to induce autophagy as a positive control ([Figure 4](#F4){ref-type="fig"}). Interestingly, *P. gingivalis*-infected MoDCs were resistant to rapamycin induced autophagy activation, relative to uninfected DCs or DCs infected with Mfa1-negative strain MFI ([Figure 4](#F4){ref-type="fig"}). We postulated that activation of Akt under *P. gingivalis* infection was responsible ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}). To test this possibility, MK2206, an allosteric pan Akt inhibitor ([@B39]), was used. Initial dose response studies established level of inhibition of Akt phosphorylation by treating the cells for 1 h with 1 and 2 μM MK2206 ([Figure 5](#F5){ref-type="fig"}). Subsequently, 1 μM MK2206 was used in all experiments in this study. As shown in previous figures, *P. gingivalis* infection alone induced phosphorylation of Akt, mTOR, Raptor and ULK1 ([Figure 5](#F5){ref-type="fig"}, lane 2). While the expression level of all of these markers were significantly decreased with rapamycin treatment ([Figure 5](#F5){ref-type="fig"}, lane 3), this effect was inhibited in DCs infected with *P. gingivalis* and treated with rapamycin ([Figure 5](#F5){ref-type="fig"}, lane 4). In addition, MK2206 not only induced Akt inhibition, but also significantly decreased phosphorylation of mTOR, Raptor and ULK1 in uninfected ([Figure 5](#F5){ref-type="fig"}, lane 5) and *P. gingivalis*-infected DCs ([Figure 5](#F5){ref-type="fig"}, lane 6). These data provide strong support for the involvement of Akt/mTOR signaling in *P. gingivalis*-induced autophagy inhibition in DCs, involving DC-SIGN receptor.

![*P. gingivalis* inhibits autophagy in DCs via Akt/mTOR-dependent manner. Representative images of immunoblot analysis of mTOR, p-mTOR, Raptor, ULK-1, and p-ULK-1. DCs were infected with *P. gingivalis* strains Pg381, DPG, and MFI for 6 h. Some groups were treated with rapamycin 1 μM while infection with *P. gingivalis*. Total cells lysates were used for Western blotting analysis. After normalization of the phosphorylated protein with the corresponding total protein, the protein signal of control was set as 1, and the signals of other groups were normalized with control to calculate fold changes.](fimmu-10-02286-g0004){#F4}

![MK2206 abrogates the influence of *P. gingivalis* on DCs autophagy. **(A)** Representative images of immunoblot analysis of Akt and p-Akt. DCs were treated with Akt inhibitor, MK2206 for 1 h. **(B)** Representative images of immunoblot analysis of Akt and p-Akt, mTOR, p-mTOR, Raptor, p-Raptor, Ulk1, and p-ULK1. DCs were pretreated with Akt MK2206 for 1 h before infection with *P. gingivalis* Pg381 for 6 h. Total cells lysates were used for Western blotting analysis. **(C--E)** Densitometric analysis of p-mTOR, p-Raptor and p-ULK1, respectively. After normalization of the phosphorylated protein with the corresponding total protein, the protein signal of control was set as 1, and the signals of other groups were normalized with control to calculate fold changes. Data are expressed as mean ± SD. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001.](fimmu-10-02286-g0005){#F5}

*P. gingivalis* Effectively Inhibits Apoptosis in DCs
-----------------------------------------------------

Having established the consistent role of Akt activation by *P. gingivalis* infection, we next sought to identify common downstream effectors of p-Akt pro-survival action. Because Akt activation often impacts the level of caspase action in cells, the expression level of cleaved caspase-3 was evaluated. Caspase-3 plays an important role in the execution-phase of the apoptosis process and is activated by both caspase 8 and caspase 9 of the intrinsic and extrinsic apoptotic pathway ([@B40]). Western blotting identified a significant decrease in the expression level of cleaved caspase-3 when DCs were infected with Pg381 or DPG3, while infection with MFI increased cleaved caspase-3 expression ([Figures 6A,B](#F6){ref-type="fig"}). Staurosporine, used as a positive control for induction of apoptosis showed the highest level of cleaved caspase-3. The expression level of Bcl2 and other members of the Bcl2 family that regulate apoptosis and autophagy in cells were also analyzed ([@B41]). DCs infected by Mfa-1 positive strains Pg381 and DPG3 increased the anti-apoptotic protein Bcl2 ([Figures 6A,C](#F6){ref-type="fig"}) while decreasing the levels of the pro-apoptotic proteins Bim and Bax ([Figures 6A,D,E](#F6){ref-type="fig"}). In contrast, DCs infected with Mfa-1 negative MFI infection did not show these alterations of the Bcl2 family members ([Figures 6A,D,E](#F6){ref-type="fig"}). In parallel with protein analysis, qPCR data showed that the mRNA expression of the pro-apoptotic genes *Bax* and *Bim* were significantly upregulated when DCs were infected with MFI, but not with Pg381 or DPG3 ([Figures 6F,G](#F6){ref-type="fig"}). On the other hand, *Bcl2* mRNA expression was significantly upregulated with Pg381 and DPG3, but not with MFI ([Figure 6H](#F6){ref-type="fig"}).

![*P. gingivalis* inhibits apoptosis in DCs. **(A)** Representative images of immunoblot analysis of Cleaved caspase-3, Bcl2, Bim, and Bax. DCs were infected with *P. gingivalis* strains, Pg381, DPG, and MFI for 6 h and total cell lysates were subjected to Western blotting analysis. Staurosporine (Stauro) was used to as a positive control to induce apoptosis in DCs. **(B--E)** Densitometric analysis of Cleaved caspase-3, Bcl2, Bim, and Bax, respectively. After normalization with total GAPDH, the protein signal of control was set as 1, and the signals of other groups were normalized with control to calculate fold changes. Cleaved caspase-3 was normalized with total caspase-3. **(F--H)** mRNA expression of Bim, Bax, and Bcl2, respectively in uninfected DCs and DC infected with *P. gingivalis* strains. mRNA levels were measured by RT-PCR and normalized to GAPDH. Data are expressed as mean ± SD. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001.](fimmu-10-02286-g0006){#F6}

To determine functionally the number of dead DCs among those infected by *P. gingivalis* strains, we analyzed the levels of propidium iodide (PI) uptake and Annexin V expression by flow cytometry. The results showed a decrease in % Annexin V in response to Mfa1 positive Pg381 and DPG3, but an increase in response to Mfa1-negative MFI ([Figure 7](#F7){ref-type="fig"}). No significant differences were detected with PI staining, indicating that cells were not undergoing necrosis. Staurosporine dissolved in DMSO was used as a positive control for apoptosis in DCs. These combined studies provide strong evidence that infected cells are resistant to apoptosis, involving upregulation of Bcl2 as a means of survival.

![*P. gingivalis* infection induces an anti-apoptotic DC phenotype. **(A)** Representative flow cytometry dot plot figures of Annexin V vs. PI. DCs were infected with *P. gingivalis* strains, Pg381, DPG, and MFI for 12 h. Annexin V and PI staining was carried out according to the manufacturer recommendation. Staurosporine (Stauro) was used to as a positive control to induce apoptosis in DCs. **(B,C)** Percentage of expression of Annexin V and PI, respectively, in control DCs and DCs infected with *P. gingivalis* strains. Data are expressed as mean ± SD. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001.](fimmu-10-02286-g0007){#F7}

*P. gingivalis*-Induced Anti-apoptotic Effect in DCs Is Akt-Dependent and Is Attenuated by MK2206 and ABT-199
-------------------------------------------------------------------------------------------------------------

To further elucidate the role of the Akt/Bcl2 axis in regulating the anti-apoptotic DC phenotype upon *P. gingivalis* infection, MK2206 was used to block Akt activation during *P. gingivalis* infection. *P. gingivalis* failed to induce DC survival upon Akt inhibition, evidenced by a significant increase in cleaved PARP and Bim, but also a decrease in Bcl2 expression ([Figures 8A--D](#F8){ref-type="fig"}), further supporting a key role of Akt in the *P. gingival*-driven DC longevity.

![MK2206 and ABT-199 attenuate the influence of *P. gingivalis* on DCs apoptosis. **(A)** Representative images of immunoblot analysis of Cleaved-PARP, Akt, p-Akt, Bcl2, and Bim. **(B--D)** Densitometric analysis of Cleaved-PARP, Akt, p-Akt, Bcl2, and Bim, respectively. After normalization of Cleaved-PARP, Akt, p-Akt, Bcl2, and Bim with GAPDH, the protein signal of control was set as 1, and the signals of other groups were normalized with control to calculate fold changes. **(E)** Representative images of immunoblot analysis of Akt, p-Akt, caspase-3 and cleaved caspase-3. **(F)** Densitometric analysis of cleaved caspase-3. After normalization of p-Akt with total Akt and cleaved caspase-3 with caspase-3, the protein signal of control was set as 1, and the signals of other groups were normalized with control to calculate fold changes. DCs were infected with *P. gingivalis* strains, Pg381, or DPG3 for 6 h. Some groups were treated with MK2206 or ABT-199 at the same time of infection. Data are expressed as mean ± SD. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001.](fimmu-10-02286-g0008){#F8}

If Bcl2 is protecting DCs from apoptosis, targeting Bcl2 should increase their susceptibility to *P. gingivalis*-induced apoptosis. ABT-199 (Venetoclax), a small molecule inhibitor that disrupts the interaction between heterodimer complex of antiapoptotic Bcl2 and its proapoptotic partners BAK/BAX, was used to attempt to specifically override the anti-apoptotic effect of Mfa1 in DCs as shown in [Figures 8E,F](#F8){ref-type="fig"}. DCs were treated with 250 nM ABT-199 ([@B42]) concurrently with P*. gingivalis* infection. ABT-199 treatment resulted in a significant increase in cleaved caspase-3 in DCs infected with *P. gingivalis* strains, that previously showed resistance to apoptosis, relative to control DCs and DCs infected with *P. gingivalis* without ABT199 treatment ([Figures 8E,F)](#F8){ref-type="fig"}. Moreover, ABT-199 treatment also resulted in a marked decrease in Akt phosphorylation in *P. gingivalis*-infected DCs ([Figures 8E,F](#F8){ref-type="fig"}).

Discussion {#s4}
==========

Periodontal disease is a multifactorial disease, with unclear pathophysiologic mechanisms contributing to its development in susceptible hosts. Several pathogens are credited with the development of periodontal disease, however *P. gingivalis*, via its virulence factors, is considered a major etiological agent of the disease ([@B43]). The mechanism whereby the periodontal pathogen, *P. gingivalis* manipulates the host immune system is not totally understood. The present study aimed to elucidate the mechanism by which *P. gingivalis* affects the two important cell survival processes, apoptosis and autophagy, in DCs. Our results show that targeting the receptor DC-SIGN in DCs by *P. gingivalis*, via its minor fimbria, results in induction of pro-survival signaling pathways, namely the Akt/FOXO1 pathway. In addition, our results also revealed that *P. gingivalis* promotes differential Akt and FOXO1 cytoplasmic/nuclear shuttling pattern, depending on *P. gingivalis* fimbrial expression. When Akt is activated, it localizes to the nucleus, where it phosphorylates and inactivates FOXO1 ([@B44]). Upon phosphorylation, FOXO1 translocates to the cytoplasm, where it undergoes polyubiquitination and subsequently proteasomal degradation, leading to inhibition of apoptosis, as FOXO members transcriptionally regulate the activation of genes encoding pro-apoptotic proteins, such as Bim ([@B45]). Not only does FOXO1 regulate cell survival, but it also plays an important role in bacterial clearance and immune cell function. Interestingly, Dong et al., using *in vivo* and *in vitro* studies of FOXO1 effect on neutrophils in response to *P. gingivalis* infection, shows that *P. gingivalis* promotes nuclear localization of FOXO1 and this effect is dependent on TLR2 ([@B46]). This suggests the influence of *P. gingivalis* on FOXO1 in the absence of strong DC-SIGN signal, which is minimally expressed in neutrophils. On the other hand, our results showed that DC-SIGN activation promotes phosphorylation of Akt and FOXO1, suggesting an override of the TLR2 signal by DC-SIGN in DCs under the influence of *P. gingivalis* minor fimbria as a strategy to evade innate immune response. This hypothesis was confirmed by activating TLR2 via Pam3csk4 concurrent with *P. gingivalis* infection. TLR2 overactivation by this route led to a significant decrease in the expression level of p-Akt. Dampening TLR2 signaling by *P. gingivalis* could be a tactic to increase the survival of its host cell, and disarm the immune response, as TLR2 signal is required for production of proinflammatory cytokines ([@B47]).

Autophagy is a process whereby the cell degrades its intracellular damaged proteins and organelles by sequestering and directing cargo to the lysosome. Autophagy is pivotal for the cell to maintain cellular homeostasis and defense against invading pathogens. By targeting intracellular bacteria to lysosomes, autophagy comprises an important element of innate immune response which is the first line of defense. Our study showed that steady state LC3B-II levels decrease upon infecting DCs with minor fimbriated *P. gingivalis* strains, suggesting inhibition of the autophagy pathway. Autophagy plays a crucial role in antigen processing leading to antigen presentation ([@B48], [@B49]), moreover previous reports of decrease in MHC class II expression on DCs from periodontitis patients ([@B50]) and in DCs infected with *P. gingivalis* ([@B30]), emphasizes the relevance of our findings to antigen presentation *in vivo*. Interestingly, several pathogens have evolved multiple ways of exploiting the host-autophagic machinery for their benefit. While *Salmonella, Mycobacterium, Brucella* and *Legionella* use the host autophagic vacuoles for replication and persistence, *Shigella* and *Listeria* escape the host autophagy process and live in the nutritionally rich cytosol ([@B51]--[@B53]). The differential utilization of the host autophagy by *P. gingivalis* has been studied before. Recently, it has been reported that *P. gingivalis* LPS, which is a ligand for TLR2, promotes autophagy of human gingival fibroblasts ([@B54]). Although previous studies demonstrated that *P. gingivalis* induces autophagy in human gingival epithelial cells for its survival ([@B55]), our previous studies have shown that it manipulates the autophagy process to survive within DCs and allow escape from immune surveillance ([@B29]). The influence of autophagy on *P. gingivalis* survival within the host is apparently a host-cell type- and bacteria strain-dependent phenomenon ([@B56]--[@B58]).

The Akt/mTOR signaling axis is an important regulator of autophagy and crucial for many aspects of cell survival during physiologic and pathologic conditions. Our results show that targeting DC-SIGN on DCs by *P. gingivalis* minor fimbria induces activation of the Akt/mTOR/ULK1 pathway. Recently, Zhao et al. demonstrated that autophagy via activation of mTOR/ULK1 enhances the killing of invading *Salmonella* ([@B59]). Thus, our study revealed that DCs infected with minor fimbriated *P. gingivalis* strains showed resistance to rapamycin-induced autophagy. The mechanism of *P. gingivalis*-infected DCs resistance to rapamycin is still unclear, however it could be attributed to the constitutive activation of Akt ([Figure 2](#F2){ref-type="fig"}). Furthermore, inhibition of Akt by MK2206 suggest that *P. gingivalis* subverts autophagy in DCs via Akt/mTOR-dependent manner. We showed that inhibition of Akt abrogates the positive influence of *P. gingivalis* on mTOR activation, decreasing phosphorylation of mTOR and its downstream effector ULK1, leading to activation of ULK1 and the autophagy process.

The results of the present study suggest that *P. gingivalis* minor fimbria induces dysregulation of autophagy and apoptosis in DCs. Apoptosis is a process by which unwanted cells are eliminated, crucial to mounting a homeostatic immune response. In this study, the regulatory role of *P. gingivalis* minor fimbria on DCs apoptosis was examined by multiple approaches, including Western blot analysis of multiple proteins involved in cell survival and death, ICC, and evaluation of phosphatidylserine localization by Annexin V labeling. In live cells, phosphatidylserine is localized to the inner leaflet of the plasma membrane. When cells engage in early stages of apoptosis, phosphatidylserine localizes to the outer leaflet due to loss of membrane asymmetry. Annexin V binds to the exposed phosphatidylserine in a calcium-dependent manner. We showed that targeting DC-SIGN leads to a decrease in Annexin V expression, suggesting inhibition of apoptosis. Perturbation of DC apoptosis can result in dire consequences such as development of autoimmune diseases ([@B60]). The Bcl2 family of proteins governs the intrinsic pathway of apoptosis. Apoptosis is inhibited when the proapoptotic members of Bcl2 family insert their BH3 domain into the hydrophobic groove, former by BH1-4 domains, of the antiapoptotic member Bcl2 ([@B61]). This interaction prevents dimerization of the antiapoptotic partners at the outer mitochondrial membrane, leading to inhibition of Cytochrome C release from the mitochondria and cleavage of executioner caspases, including caspase-3, hence apoptosis process is inhibited.

We further showed that *P. gingivalis* minor fimbriated strains induce an increase in the anti-apoptotic Bcl2 protein expression and a decrease in pro-apoptotic proteins Bim, Bax and cleaved caspase-3, promoting survival of DCs. Importantly, deficiency in Bim has been contributed to breakdown of immune tolerance and the development of autoimmune diseases in Bim knockout mice ([@B62]). In addition, the increase in Bcl2 expression shown in [Figure 6](#F6){ref-type="fig"} could be attributed to the increase in Akt activation, as suggested previously by Pugazhenthi et al. ([@B63]).

Consistent with a key role for Bcl2 overexpression in DC survival was the ability of ABT-199 to induce apoptosis in *P. gingivalis-*infected DCs. ABT-199 is a small molecule inhibitor that selectively binds to Bcl2 and currently is being used in clinical trials for cancer treatment ([@B42]). Our results also showed that ABT-199 treatment decreased phosphorylation of Akt in *P. gingivalis*-infected DCs, consistent with findings of previous work that suggested regulation of cell survival via Bcl2-mediated activation of Akt ([@B64]). Using *in vitro* and *in vivo* experiments, Zhan et al. described the potency of ABT199 to kill plasmacytoid DCs associated with systemic lupus erythematosus ([@B65]). These findings together suggest the possibility of using pharmacological agents as a new modality to inhibit prolonged survival of *P. gingivalis*-infected DCs.

Abnormal survival of microbe-loaded DCs is expected to contribute to systemic inflammation and microbial dissemination to distant sites. Carrion et al., using post-mortem analysis of coronary artery samples from patients with coronary artery disease and periodontal disease, showed localization of *P. gingivalis*-infected DCs in atherosclerotic plaques and co-localization of DCs marker, DC-SIGN, with *P. gingivalis* minor fimbria protein Mfa-1 ([@B12]). This could be a result of *P. gingivalis* exploiting migrating DCs, endowed with impaired pathogen clearance and extended survival, to travel to permissive distant sites.

In summary, considering the limitations of the present *in vitro* study, we have identified important roles for the fimbrial phenotype of *P. gingivalis* in activation of a signaling pathway involved in downregulation of both apoptosis and autophagy in DCs. This pathways is shown diagrammatically in [Figure 9](#F9){ref-type="fig"}. It is noteworthy that the absence of a functional DC-SIGN ortholog in murine DCs ([@B66]--[@B68]) makes it difficult to confirm these results in mouse model of infection; however, this same pathway has been shown to be activated *in vivo* in gingival tissues and blood cells of subjects with periodontitis ([@B34]). In addition, our recent clinical pilot study has shown that periodontitis (PD) patients exhibit low autophagic profile and decreased autophagy-related proteins expression relative to healthy subjects ([@B69]). The same study also shows that placing periodontitis patients on Vitamin D supplementation, which supports an anti-inflammatory, pro-autophagy environment restores autophagy and increases the expression of the autophagy-related proteins in PD patients. We would thus suggest that efforts to restore immune homeostasis in PD patients consider the promotion of antimicrobial autophagy and apoptosis to prevent untoward inflammatory responses in the periphery and increase bacterial clearance.

![Anti-autophagic and anti-apoptotic pathway activated in human DCs by *P. gingivalis* and its fimbria proteins. Targeting the receptor DC-SIGN on human DCs by *P. gingivalis* Mfa1 fimbria results in the activation of Akt, which phosphorylates and inactivates FOXO1 resulting in anti-apoptotic DCs phenotype, thereby extending the lifespan of host DCs. The activation of Akt results also in activation of Akt/mTOR signaling axis, which inhibits antimicrobial autophagic machinery in human DCs, resulting in survival of intracellular *P. gingivalis*.](fimmu-10-02286-g0009){#F9}
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